Low Prevalence of Lung Obstruction, Restriction in COVID-19 After ICU Discharge
Researchers observed a low prevalence of lung obstruction and restriction and either mild or no cognitive impairment in patients with COVID-19 after ICU discharge.
All articles by Brandon May
High Rates of Acute Cardiovascular Events Among Hospitalized Patients With Influenza
The rate of acute cardiovascular events was found to be high in adults hospitalized with influenza.
Oral Antibiotic Therapy the Day Before Colon Surgery Reduces Incidence of Surgical-Site Infections
The use of prophylactic oral antibiotic in the day prior to elective colon surgery is associated with a reduced incidence of surgical-site infections.
Administering Oxygen Therapy May Increase Infection Risk in Healthcare Workers
Healthcare workers caring for patients with viral severe acute respiratory infection have an increased risk of infection if they are administering oxygen therapy to their patients.
Comorbid Asthma and COVID-19: Risk Factors for Hospitalization, Mortality
Researchers may have identified several risk factors for hospitalization, intensive care, and mortality in patients with COVID-19 and comorbid asthma.
Comorbid Diabetes and COVID-19 Linked to Longer Hospitalization
This study found that diabetic patients with COVID-19 had lower lymphocyte counts and hospital stays.
Subclinical Bacteria in Home May Contribute to Poor Asthma Control
Subclinical bacteria in the home environment likely influence the airway microbiome and contribute to poor asthma control in patients with refractory asthma.
Convalescent Plasma Transfusion Appears Safe for Patients With COVID-19
The transfusion of human convalescent plasma as a mitigation and treatment option for patients with COVID-19 is associated with a low rate of serious adverse events.
Inflammatory Bowel Disease Associated With Higher Bacterial, Viral Meningitis Risk
Study finds that patients with IBD and 1 or more comorbidities are at increased risk for viral or bacterial meningitis.
Ixekizumab May Prevent Reactivation of Tuberculosis in Patients With Latent Tuberculosis Infection
Study data support the use of therapeutic antibodies targeting IL-17A, such as ixekizumab, in patients with latent tuberculosis infection.
-
Loading...
-
Loading...
Next post in Respiratory
